Using differential mass spectrometry and proteomics, we identified three putative biomarkers for AD selected by the key words “oligodendrocyte” or “axon” or “myelin”: aldehyde-dehydrogenase 1A1, alpha-synuclein and protein S100-A4. The gene discussed is S100A4; the disease is Alzheimer disease.